ENTA
Enanta Pharmaceuticals Inc
NASDAQ: ENTA · HEALTHCARE · BIOTECHNOLOGY
$13.87
+1.17% today
Updated 2026-04-29
Market cap
$386.25M
P/E ratio
—
P/S ratio
5.77x
EPS (TTM)
$-3.21
Dividend yield
—
52W range
$5 – $17
Volume
0.2M
Enanta Pharmaceuticals Inc (ENTA) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
6 of 8
Last 8 quarters
Avg EPS surprise
+18.1%
Last 4 quarters
Revenue YoY growth
+9.8%
Most recent quarter
EPS YoY growth
+60.0%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
+1.7%
Last 2 reports
Positive reaction rate
50%
1 of 2 quarters
Largest single-day move
+4.6%
2026-02-09
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-02-09 | $-0.42 | +48.1% | $13.51 | $14.13 | +4.6% |
| 2025-12-01 | $-0.87 | +13.9% | $14.12 | $13.96 | -1.1% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.81 | $-0.42 | +48.1% | $18.61M | +9.8% |
| 2025-09-30 | $-1.01 | $-0.87 | +13.9% | $15.13M | +3.5% |
| 2025-06-30 | $-0.88 | $-0.85 | +3.4% | $18.31M | +1.9% |
| 2025-03-31 | $-1.14 | $-1.06 | +7.0% | $14.93M | -12.5% |
| 2024-12-31 | $-1.35 | $-1.05 | +22.2% | $16.96M | -5.8% |
| 2024-09-30 | $-0.92 | $-1.36 | -47.8% | $14.61M | -22.8% |
| 2024-06-30 | $-1.45 | $-1.07 | +26.2% | $17.97M | -4.9% |
| 2024-03-31 | $-1.33 | $-1.47 | -10.5% | $17.05M | — |
| 2023-12-31 | $-1.19 | $-1.58 | -32.8% | $18.00M | — |
| 2023-09-30 | $-2.15 | $-1.33 | +38.1% | $18.93M | — |
| 2023-06-30 | $-2.34 | $-1.86 | +20.5% | $18.89M | — |
Frequently asked questions
Has Enanta Pharmaceuticals Inc beaten earnings estimates?
Enanta Pharmaceuticals Inc has beaten Wall Street EPS estimates in 6 of its last 8 quarterly reports, with an average EPS surprise of +18.1% over the last 4 quarters.
How does ENTA stock react to earnings?
ENTA stock has moved an average of +1.7% in the trading day following earnings over its last 2 reports, with positive reactions in 50% of those quarters.
What is Enanta Pharmaceuticals Inc's revenue growth rate?
Enanta Pharmaceuticals Inc reported year-over-year revenue growth of +9.8% in its most recent quarter, with EPS growing +60.0% year-over-year.